.On the heels of an FDA denial for its own chief rival Novo Nordisk, Eli Lilly is actually picking u...
.Simply a handful of months after dosing the initial patient in a period 2 test for recently identif...
.Eli Lilly's look for weight problems aim ats has led it to the dark genome. The Big Pharma has come...
.Arsenal Biosciences is actually going on up. The cell therapy provider has added $325 thousand in a...
.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has submitted ...
.Aelis Farma's chances of safeguarding a quick, favorable decision on a $100 million choice payment ...
.ProKidney has ceased some of a pair of phase 3 trials for its tissue therapy for renal ailment afte...
.Vaxcyte unveiled what experts called "magnificent" phase 1/2 data for its own 31-valent pneumococca...
.Recursion has discovered by means of a very early test of its own tech-enabled strategy to medicine...
.Contact it an instance of really good chemistry: Acepodia, a biotech based upon Nobel Champion scie...